help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2007-0400
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/2/344    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by He, B.
Right arrow Articles by O’Malley, B. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, B.
Right arrow Articles by O’Malley, B. W.
Molecular Endocrinology 22 (2): 344-360
Copyright © 2008 by The Endocrine Society

A Repressive Role for Prohibitin in Estrogen Signaling

Bin He, Qin Feng, Atish Mukherjee, David M. Lonard, Francesco J. DeMayo, Benita S. Katzenellenbogen, John P. Lydon and Bert W. O’Malley

Department of Molecular and Cellular Biology (B.H., Q.F., A.M., D.M.L., F.J.D., J.P.L., B.W.O.), Baylor College of Medicine, Houston, Texas 77030; and Department of Molecular and Integrative Physiology (B.S.K.), University of Illinois, Urbana, Illinois 61801

Address all correspondence and requests for reprints to: Bert W. O’Malley, Department of Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030. E-mail: berto{at}bcm.tmc.edu.

Nuclear receptor-mediated gene expression is regulated by corepressors and coactivators. In this study we demonstrate that prohibitin (PHB), a potential tumor suppressor, functions as a potent transcriptional corepressor for estrogen receptor {alpha} (ER{alpha}). Overexpression of PHB inhibits ER{alpha} transcriptional activity, whereas depletion of endogenous PHB increases the expression of ER{alpha} target genes in MCF-7 breast cancer cells. Chromatin immunoprecipitation experiments demonstrate that PHB is associated with the estrogen-regulated pS2 promoter in the absence of hormone and dissociates after estradiol treatment. We demonstrate that PHB interacts with the repressor of estrogen receptor activity (REA), a protein related to PHB, to form heteromers and enhance the protein stability of both corepressors. Interestingly, the corepressor activity of PHB is cross-squelched by the coexpression of REA (and vice versa), suggesting that PHB and REA repress transcription only when they are not paired. We further demonstrate that coiled-coil domains located in the middle of PHB and REA are responsible for their heteromerization, stabilization, and cross-squelching actions. Finally, ablation of PHB function in the mouse results in early embryonic lethality, whereas mice heterozygous for the PHB null allele exhibit a hyperproliferative mammary gland phenotype. Our results indicate that PHB functions as a transcriptional corepressor for ER{alpha} in vitro and in vivo, and that its heteromerization with REA acts as a novel mechanism to limit its corepressor activity.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  PR
Coregulators:   REA  |  AIB1
Ligands:   17β-Estradiol  |  R5020



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. A. Ross, Z. S. Nagy, and R. A. Kirken
The PHB1/2 Phosphocomplex Is Required for Mitochondrial Homeostasis and Survival of Human T Cells
J. Biol. Chem., February 22, 2008; 283(8): 4699 - 4713.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society